George F Widhopf, Ii

Title: Innovations by George F Widhopf, II

Introduction

George F Widhopf, II is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of therapeutic antibodies, particularly in the context of cancer treatment. With a total of 12 patents to his name, Widhopf's work is at the forefront of medical innovation.

Latest Patents

Widhopf's latest patents include groundbreaking inventions such as therapeutic antibodies against the ROR-1 protein. These antibodies have binding specificity for ROR-1 expressed on cancer cells, particularly leukemic and lymphomic cells. His patents also encompass pharmaceutical compositions containing these antibodies for use in treating cancer. Additionally, he has developed methods for diagnosing such cancers through in vitro detection of binding to the ROR-1 protein expressed on putative cancer cells. Another notable invention involves antibodies and vaccines aimed at treating ROR1 cancers and inhibiting metastasis. This invention relates to pharmaceutical compositions and methods of inhibiting metastasis using anti-ROR1 antibodies or antigen binding fragments, ROR1 binding peptides, and ROR1 vaccines.

Career Highlights

Widhopf is affiliated with the University of California, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer therapies and diagnostics.

Collaborations

Widhopf has collaborated with notable colleagues, including Thomas James Kipps and Bing Cui, who contribute to the research and development of his innovative projects.

Conclusion

George F Widhopf, II exemplifies the spirit of innovation in the medical field, particularly through his work on therapeutic antibodies for cancer treatment. His contributions are paving the way for new diagnostic and therapeutic strategies in oncology.